As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

HealthDay News — Opportunistic bilateral salpingectomy (OBS) is associated with a risk reduction in serous ovarian carcinoma, according to a research letter published online Feb. 2 in JAMA Network ...

Most uterine cancers have excellent five-year survival rates – up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 ...

A new research paper was published in Volume 12 of Oncoscience on October 14, 2025, titled "Bridging clinical insight and laboratory model in high-grade serous ovarian carcinoma (HGSOC) using DNA ...

Researchers have identified the origin of ovarian cancer that develops in the fallopian tube, which opens doors to discovering new methods for diagnosing the disease and potential therapies. The ...

Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to ...

A prevention strategy developed by Canadian researchers can reduce the risk of the most common and deadly form of ovarian cancer by nearly 80%, according to a new study published today in JAMA Network ...

The FDA granted accelerated approval to the combination of avutometinib and defactinib (Avmapki Fakzynja Co-pack) for the treatment of adults with KRAS-mutated, recurrent low-grade serous ovarian ...

Many women chalk up bloating or stomach changes to menopause — but experts warn these subtle signs are exactly why ovarian cancer is so often diagnosed late. If the risk climbs sharply after 45, how ...

An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at the University of Utah (the U) and Emory University, revealed that Black ...